Wyatt A. Gotbetter

Board of Directors

​

Wyatt A. Gotbetter is a seasoned life sciences executive and strategy consulting leader experienced in asset and franchise growth strategy, life cycle management and M&A/ transaction advisory support, having advised on or supported integration of >$40B in life sciences transactions. He currently is the Global Head for Evidence, Value and Access for Cytel, Inc. Previously he has served with leading life sciences and consulting entities, including Senior Vice President leading the Market Access and Health Economics business for global CRO  Parexel;  Partner for Parexel's consulting subsidiary Health Advances, and has served as a manager in the life sciences practice of Boston Consulting Group (BCG) and head of New Product Commercialization for Biogen, leading commercial strategy across the company’s pipeline. He also supported product strategy and launches at Boston Scientific, following leadership of Decision Resources Group (DRG) consulting

 

Mr. Gotbetter earned his Bachelor of Science and Master of Public Administration degrees with a focus on health economics from Cornell University, where he is an Executive-in-Residence and adjunct faculty for the Sloan Health Management graduate program. He also teaches the annual valuation course at the BIO International Conference, as a member of the Business Development Fundamentals faculty, and has presented at conferences for the Drug Information Association where he is the Evidence, Pricing and Access editor for their Global Forum publication.